ECOG-ACRIN A Randomized Phase III Study of BRAF-Targeted Therapy vs Cabozantinib in RAI-Refractory Differentiated Thyroid Cancer with BRAF V600Em Adult CIRB - Late Phase Emphasis Active Available to Open